Literature DB >> 24825180

Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.

Joshua R Lewis1, Deka Barre, Kun Zhu, Kerry L Ivey, Ee Mun Lim, Jeff Hughes, Richard L Prince.   

Abstract

Proton pump inhibitors (PPIs) are widely used in the elderly. Recent studies have suggested that long-term PPI therapy is associated with fractures in the elderly, however the mechanism remains unknown. We investigated the association between long-term PPI therapy ≥1 year and fracture risk factors including bone structure, falls, and balance-related function in a post hoc analysis of a longitudinal population-based prospective cohort of elderly postmenopausal women and replicated the findings in a second prospective study of falling in elderly postmenopausal women. Long-term PPI therapy was associated with increased risk of falls and fracture-related hospitalizations; adjusted odds ratio (AOR) 2.17; 95% CI, 1.25-3.77; p = 0.006 and 1.95; 95% CI, 1.20-3.16; p = 0.007, respectively. In the replication study, long-term PPI use was associated with an increased risk of self-reported falling; AOR, 1.51; 95% CI, 1.00-2.27; p = 0.049. No association of long-term PPI therapy with bone structure was observed; however, questionnaire-assessed falls-associated metrics such as limiting outdoor activity (p = 0.002) and indoor activity (p = 0.001) due to fear of falling, dizziness (p < 0.001) and numbness of feet (p = 0.017) and objective clinical measurement such as Timed Up and Go (p = 0.002) and Romberg eyes closed (p = 0.025) tests were all significantly impaired in long-term PPI users. Long-term PPI users were also more likely to have low vitamin B12 levels than non-users (50% versus 21%, p = 0.003). In conclusion, similar to previous studies, we identified an increased fracture risk in subjects on long-term PPI therapy. This increase in fracture risk in elderly women, already at high risk of fracture, appears to be mediated via increased falls risk and falling rather than impaired bone structure and should be carefully considered when prescribing long-term PPI therapy.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ADVERSE EVENTS; FALLS; FRACTURE; PROTON PUMP INHIBITOR THERAPY; VITAMIN B12

Mesh:

Substances:

Year:  2014        PMID: 24825180     DOI: 10.1002/jbmr.2279

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  35 in total

1.  Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.

Authors:  Tanya M Wildes; Ronald J Maggiore; William P Tew; David Smith; Can-Lan Sun; Harvey Cohen; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cynthia Owusu; Cary P Gross; Hyman Muss; Andrew Chapman; Stuart M Lichtman; Vani Katheria; Arti Hurria
Journal:  Support Care Cancer       Date:  2018-04-28       Impact factor: 3.603

2.  [Identification, diagnostics and guideline conform therapy of osteoporosis (DVO) in trauma patients : a treatment algorithm].

Authors:  C Neuerburg; R Schmidmaier; S Schilling; C Kammerlander; W Böcker; W Mutschler; U Stumpf
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

Review 3.  Adverse bone effects of medications used to treat non-skeletal disorders.

Authors:  N B Watts
Journal:  Osteoporos Int       Date:  2017-07-27       Impact factor: 4.507

4.  Proton-pump inhibitors and risk of fractures: an update meta-analysis.

Authors:  B Zhou; Y Huang; H Li; W Sun; J Liu
Journal:  Osteoporos Int       Date:  2016-01       Impact factor: 4.507

Review 5.  Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.

Authors:  Marina L Maes; Danielle R Fixen; Sunny Anne Linnebur
Journal:  Ther Adv Drug Saf       Date:  2017-06-29

Review 6.  Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.

Authors:  Takeshi Kanno; Paul Moayyedi
Journal:  Curr Gastroenterol Rep       Date:  2019-12-05

7.  Association of Proton Pump Inhibitor Use with Recurrent Falls and Risk of Fractures in Older Women: A Study of Medication Use in Older Fallers.

Authors:  H W Thaler; C S Sterke; T J M van der Cammen
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

Review 8.  The relationship between long-term proton pump inhibitor therapy and skeletal frailty.

Authors:  Arthur N Lau; Michael Tomizza; Matthew Wong-Pack; Alexandra Papaioannou; Jonathan D Adachi
Journal:  Endocrine       Date:  2015-05-07       Impact factor: 3.633

9.  Proton pump inhibitor use and the risk of fractures among an older adult cohort.

Authors:  Barbara N Harding; Noel S Weiss; Rod L Walker; Eric B Larson; Sascha Dublin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-28       Impact factor: 2.890

10.  Proton pump inhibitors and fracture risk. The HUNT study, Norway.

Authors:  M Hoff; E Skovlund; S Skurtveit; H E Meyer; A Langhammer; A J Søgaard; U Syversen; S Forsmo; B Abrahamsen; B Schei
Journal:  Osteoporos Int       Date:  2019-11-18       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.